MicroMedTec Closes on￥10M Pre-A Round, with its Aneurysm Sealing Product into Clinical Trails

According to VCBeat, Shanghai Micro Medical Technology Co., Ltd. ("MicroMedTec") has completed the series Pre-A financing of tens of millions yuan from CD Capital. Proceeds of this round will be used to promote the company's interventional aneurysm treatment product "MeshCoil" for aneurysm sealing, into clinical research. MicroMedTec raised millions of yuan in an angel round of financing in November 2018.

MicroMedTec is a medical equipment company that develops interventional treatment products for cerebrovascular diseases. The company focuses on minimally invasive treatments and is committed to providing new solutions for cerebrovascular patients. At present, it has developed "MeshCoil" for minimally invasive interventional therapy of intracranial hemorrhagic aneurysms.

Xiang Yonggang, the founder and CEO of MicroMedTec, has 15 years of experience in the minimally invasive medical device industry, once serving as the senior R&D engineer and director of R&D in well-known medical device companies, and successfully developed several advanced products with 50 patents, several of which were authorized by the European Patent Office.

The founding team of MicroMedTec also includes domestic and foreign senior engineering and technical talents and clinical experts. The R&D strength of the company has laid a solid foundation for the subsequent launch of more innovative medical products in MicroMedTec.

At present, MicroMedTec is cooperating with a number of first-class hospitals to do the clinical research of its products. In the future, the company will further expand its product line for the treatment of intracranial aneurysms, including blood diversion products before aneurysm breakage and interventional therapy products after the breakage.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with a total size of US$600 million. The company is operated by a professional team with diversified and profound industry backgrounds.

CD Capital has made over 40 investments with high growth potential and earned a reputation as a premier venture capital firm with the main focus on the China healthcare industry.